The Mexican health agency (Cofepris) issued warnings about the dangers of self-medicating with GLP-1 agonists. Specialists alert that the rising global demand for weight loss drugs has caused an increase in falsified versions circulating in numerous countries, including Mexico.

Cofepris alertó por los peligros de automedicarse con pastillas para perder peso, como los que contienen GLP-1. <p>La creciente demanda mundial de <a href="https://www.elfinanciero.com.mx/salud/2025/11/23/asi-es-como-ozempic-y-los-nuevos-medicamentos-para-bajar-de-peso-cambian-el-tratamiento-de-la-diabetes/" rel="noreferrer" target="_blank" title="https://www.elfinanciero.com.mx/salud/2025/11/23/asi-es-como-ozempic-y-los-nuevos-medicamentos-para-bajar-de-peso-cambian-el-tratamiento-de-la-diabete...